Hypoxia Potentiates Glioma-Mediated Immunosuppression
2011

Hypoxia Increases Glioma-Mediated Immunosuppression

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wei Jun, Wu Adam, Kong Ling-Yuan, Wang Yongtao, Fuller Gregory, Fokt Isabella, Melillo Giovanni, Priebe Waldemar, Heimberger Amy B.

Primary Institution: The University of Texas M. D. Anderson Cancer Center

Hypothesis

Hypoxia potentiates the innate and adaptive immunosuppressive properties of gliomas.

Conclusion

Hypoxia enhances glioma-mediated immunosuppression, which can be reversed with therapeutic inhibition of specific pathways.

Supporting Evidence

  • Hypoxia increased the production of immunosuppressive cytokines by glioblastoma-associated cancer stem cells.
  • Under hypoxic conditions, T cell proliferation was inhibited more than under normoxic conditions.
  • Hypoxia enhanced the induction of regulatory T cells from T cells exposed to glioblastoma stem cell supernatants.
  • Phagocytosis by monocytes was significantly inhibited by supernatants from hypoxic glioblastoma stem cells.

Takeaway

When there isn't enough oxygen, glioma cells become better at stopping the immune system from fighting them, but we can use certain drugs to help the immune system work better.

Methodology

The study compared the immunosuppressive properties of glioblastoma-associated cancer stem cells under normoxic and hypoxic conditions.

Potential Biases

Potential bias in interpreting results due to the use of a limited number of glioma samples.

Limitations

The study primarily focused on in vitro conditions, which may not fully replicate the in vivo tumor microenvironment.

Participant Demographics

Human glioblastoma patients, specific demographics not detailed.

Statistical Information

P-Value

0.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016195

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication